The Power of the Network

HBA Special Feature The Power By Taren Grom of the Network Internal women’s networks, he Healthcare Businesswomen’s Association has one of the most influential otherwise known as ERGs — networks in the industry. The organization has been successful in building powerful employee resource groups Tcommunities, including its Rising Star and Luminary honorees, as well as being a valued consultant to many of its corporate partners to guide the build-out of their — can provide a powerful internal women’s networks. means for women at all levels to build and nurture a network For more than 15 years, PharmaVOICE In this special feature, we showcase all has been proud to support the HBA’s Rising 117 Rising Stars and Luminaries, many of that can deliver personal and Star and Luminary program and showcase whom have identified their leadership style professional benefits. more than 1,500 of the industry’s brightest and what works for them. We also learn from and most talented leaders. And this year is no these visionaires what they believe will be the One of the unique advantages of being exception. These women have been recognized most impactful trends in the coming years. named a Rising Star or Luminary, is that these by their organizations for their contributions And new this year, this special feature kicks women now belong to an exclusive group. to the business, leadership as a role model, off with more than a dozen sponsored profiles They have the opportunity to build their mentorship, dedication to the healthcare in- of Rising Stars and Luminaries, who provide networks from among some of the most di- dustry, and for being a true example of what their inspirational leadership stories in their verse and talented group of individuals in the top talent looks like. own words. PharmaVOICElife-sciences industry. of

WE COULD NEVER SHORTEN 67% OF OUR PEOPLE ARE WOMEN. THE DISTANCE FROM LAB TO LIFE WITHOUT THEM. Compliments

At Syneos HealthTM, we combine some of the best strategic brains in the biopharmaceutical industry with passion, drive and endless energy to help bring your product from lab to life.

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] Please join us in congratulating two of our best, Kari L. Delahunty and Tara Fitzgerald, on their inclusion among the 2019 HBA Honorees.

syneoshealth.com

ISO 12647-7 Digital Control Strip 2009 3% A 100 60 100 70 30 100 60 100 70 30 100 60 100 70 30 100 40 40 100 40 100 40 70 40 70 40 40 40 70 40 40 70 40 70 40 40 3 10 25 50 75 90 100

B 100 100 60 100 100 70 70 30 30 100 100 60 100 100 70 70 30 30 100 100 60 100 100 70 70 30 30 100 40 100 40 40 100 10 40 40 20 70 70 70 70 40 70 40 40 0 0 0 0 3.1 2.2 2.2 10.2 7.4 7.4 25 19 19 50 40 40 75 66 66 100 100 100 80 70 70 100 1 Syneos_HBA_PharmaVoiceHPSprd_18x5.5_HalfInchGutterNoDropShadow.indd Saved at 4-10-2019 5:49 PM from Suk’s iMac by Suk Choi / Suk Choi Printed At None

Job info Approvals Fonts & Images Job None Art Director None Fonts Client None Copywriter None Montserrat (Light, Medium) Media Type None Account Mgr None Live 17.5” x 5” Studio Artist None Images Trim 18” x 5.5” Proofreader None Syneos Health_rgb-LOGO-LOCKUP®-Larger.ai (18.88%), GettyImages-938493922.tif (CMYK; Bleed 18.5” x 6” 734 ppi; 40.84%), GettyImages-538618344.tif (CMYK; 607 ppi; 49.41%), ControlStrip.eps (100%) Pubs None Notes Inks None Cyan, Magenta, Yellow, Black HBA Special Feature

IWNs: A Win-Win A recent study by researcher Shawn Achor reveals that women’s forums that strike a healthy mix of social connection, support, and mo- HBA ACE Award Winners tivation create lasting intellectual, professional, and financial results for female participants. In addition, a 2017 study showed 86% of female 2018 — Pfizer, Insigniam and KPMG respondents believe participating in their corporate women’s employee resource groups, or ERGs, specifically benefitted them and their career. 2017 — Bristol-Myers Squibb and athenahealth And 70% of those respondents said their women’s ERGs had actually 2016 — Quest Diagnostics’ Women in Leadership Initiative helped to create policy changes at work. 2015 — Roche Diagnostics’ Women Leadership Initiative (WLI) A number of HBA corporate partners have very successful internal women’s network (IWN) programs in place, some are long-established 2014 — Baxter Women Leaders Business Resource Group and some are fairly recent. PharmaVOICE had a chance to connect with a 2013 — Quintiles’ Women Inspired Network (WIN) few of these companies to learn about their best practices and programs. 2012 — Cardinal Health Women’s Initiative Network (WIN) At Amgen, diversity matters. The company strongly believes in the importance of inclusion in the workplace to foster collaboration, innova- 2011 — Bayer Healthcare’s Women’s Leadership Initiative (WLI) tion, and a positive culture. To create the best place for talent, Amgen 2010 — The WISE program from sanofi-aventis US Canada launched its chapter of Amgen’s global initiative Women Em- powered to be Exceptional (WE2) on International Women’s Day in 2009 — Abbott’s Women Leaders in Action (WLA) Employee Network 2019. Ponda Motsepe-Ditshego, M.D., a 2019 HBA Rising Star heads 2008 — Novartis Pharmaceuticals Women’s Initiatives – EWIN/WIL up the chapter as its executive sponsor along with Dr. Francesco Di 2007 — Johnson & Johnson Women’s Leadership Initiative Marco, Amgen Canada’s VP and general manager. “WE2’s mission is to empower women of Amgen to deliver exceptional results,” she says. “Available to women and men, the chapter W2O, a privately held, healthcare-focused marketing communica- strives to build a diverse and inclusive workforce that is critical to Am- tions firm, with more than 700 people and 13 offices across the United gen’s innovation and the success of all staff within the organization.” States and Europe, recently launched its internal women’s network — As an unabashed champion of women and mother to a young girl, Women of W2O — also known as WOW. Ponda is a tireless advocate for creating a culture of inclusion and devel- Casey Cole, group director, people experience, at W2O, says WOW opment for young girls and women and is heavily involved with STEM is one of the first ERGs at the agency, and one that ensures that the initiatives in her personal capacity as well as in her role at Amgen. culturePharmaVOICE is as inclusive as possible, as welcoming as possible, and as of

WE COULD NEVER SHORTEN 67% OF OUR PEOPLE ARE WOMEN. THE DISTANCE FROM LAB TO LIFE WITHOUT THEM. Compliments

At Syneos HealthTM, we combine some of the best strategic brains in the biopharmaceutical industry with passion, drive and endless energy to help bring your product from lab to life.

Please join us in congratulating two of our best, Kari L. Delahunty and Tara Fitzgerald, on their (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] inclusion among the 2019 HBA Honorees. syneoshealth.com

ISO 12647-7 Digital Control Strip 2009 3% A 100 60 100 70 30 100 60 100 70 30 100 60 100 70 30 100 40 40 100 40 100 40 70 40 70 40 40 40 70 40 40 70 40 70 40 40 3 10 25 50 75 90 100

Women’s Network Best Practices CAROL WELLS By striving to continuously improve their women’s Genentech networks, top employers acknowledge an ultimate truth when it comes to managing and engaging talent: Genentech’s GWP has a synergistic what got you here won’t get you there. Many ERGs relationship with the HBA, through are contributing to the success of their organizations which Genentech women by increasing the talent pipeline of women, fostering relationships and belonging, and ensuring alignment have the opportunity to network, between their business and diversity initiatives. These be mentored, and develop ERGs are not just good for business, they are essential. additional skills. The best practices below show how successful women’s networks can reinvigorate their initiatives to be more inclusive and impactful:

1. Become an Intelligence Engine Surveying women’s networks on their preferences about professional development activities is common- place enough. But undertaking a study of the female experience for your organization is a strong demon- stration that you want women to feel a sense of be- that supports W2O’s strategic goals. WOW longing. Conducting such a comprehensive study does is an organic enterprise fostered by a group more than simply inform leaders about the experience of six millennials to create an inclusive and of women, it can also further codify the work and mem- innovative culture as well as one that supports bership of the network. It also raises awareness among W2O’s strategic goals. leadership and gives them a platform to take action. As the sponsor of WOW Angela Gillespie, president, W2O wcg, guided the core team 2. Bolster Executive Sponsorship by Looking to ensure WOW’s core mission was based on Outside and Inside the ERG education, tied to the agency’s overall mission, By now, we’ve all heard that executive sponsorship is PharmaVOICEand was open to everyone in the agency. important to the success of an ERG. Consider have an “What I am so proud of is that this work influential, connected chair running the group. isn’t being prescribed by leadership; it’s growing organically in the hallways and in the con- 3. Promote Men’s Belonging of DR. PONDA MOTSEPE-DITSHEGO ference rooms and in the hearts of our people,” Bolstering men’s participation in women’s networks Amgen Canada Angela says. “And, for me, this is such an au- can require thinking through everything from a long- thentic way to build community and culture. term vision and strategy to the simplest marketing WE2’s mission is to empower women At every meeting, we review WOW’s strategic signifiers. of Amgen to deliver exceptional goals and think about how we can support results. Available to women and diversity and inclusion through our own talent 4. Turn ERG Volunteer Roles into True Career acquisition and development programs and Development Opportunities men, the chapter strives to build a how we transfer that to our clients by develop- While ERGs can provide opportunities to muscle-up on diverse and inclusive workforce that ing best practices that can extend and connect hard skills, they also build on the subtleties of softer is critical to Amgen’s innovation and our company to the industry at large.” skills. Volunteers were given a risk-free environment in the success of all staff within the To illustrate this point, the W2O team which to develop new skills that would ultimately add organization. is providing strategic recommendations to value to the business. elevate its female clients within their own organizations and within the industry. “We have 5. Think Globally, Act Locally put together analytics and insights that inform How does an organization promote a sense of belong- engaging and compelling as possible. “We thought leadership opportunities, media op- ing across cultures? Weave, scatter, and intermingle believe strongly that making sure our culture portunities, and gender parity conferences for leaders and members. is both inclusive and engaging helps drive re- our clients to participate in to illustrate how tention and talent acquisition as well as helps diversity and inclusion drives positive business 6. Build Bridges to TopCompliments Female Leaders us connect with our clients in a really smart, results,” Angela says. “We want our clients When rising stars look up and see few leaders who are innovative, and interesting way,” she says. to be on the cutting-edge and have the best female; those stars may dismiss their own interest in a WOW kicked off earlier this year with its practices for diversity and inclusion, and we top role — seeing it as implausible. Put another way, first event, an educational program that drew are ready to help them.” they want to see it to be it. Creative companies are more than 150 employees in person and vir- And W2O walks the walk and talks the findings ways to showcase their established female tually from the agency’s various global offices. talk. The agency has standout numbers when leadership and connect them to aspiring leaders. (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] WOW was an organic enterprise fostered it comes to diversity: 67% of its workforce is Source: HR.com, March 3, 2018, Selena Rezvani and Jo Miller. by a group of six millennials to create an in- female, 71% of females are in senior director clusive and innovative culture as well as one roles or above, and 83% of the agency’s presi-

31 May 2019  PharmaVOICE HBA Special Feature

his largest employee contingency. To CASEY COLE achieve its goals, the company imple- W2O mented a number of We believe strongly that making pipeline and development initiatives sure our culture is both inclusive and to drive to the goal, engaging helps drive retention and which was achieved. talent acquisition as well as helps us In addition, Carol connect with our clients in a really says the company smart, innovative, and interesting way. holds a leadership . summit, which just celebrated its 10th anniversary, every year for its top female lead- companies of all sizes and companies are not ers, and every year it sells out. required to be HBA corporate partners to Carol, who is an HBA STAR honoree and apply. Up to three winners will be selected advocate for the association, notes there is a and recognized at the 2019 HBA annual con- ANGELA GILLESPIE synergistic relationship between the GWP and ference in San Diego in November. (For more W2O, wcg the HBA through which Genentech women information, please visit hbanet.org.) can have the opportunity to network, be In 2018, the HBA recognized Pfizer, Insig- We have put together analytics mentored, and develop additional skills with niam, and KPMG as ACE winners for their ex- and insights that inform thought people outside of the organization, which is emplary workplace initiatives that are helping leadership opportunities, media hugely beneficial. to advance women and drive gender parity in opportunities, and gender parity This year, Genentech recognized Jennifer the business of healthcare. The 2018 honorees conferences for our clients to Foley, global head, business insights and an- joined an elite group of organizations that are participate in to illustrate how alytics (BIA), product development clinical committed to realizing the full potential of operations and Saileta Prabhu, Ph.D., senior their female talent pool by fostering programs diversity and inclusion drives positive director, development sciences, as its Rising that deliver impactful and measurable results. business results. Stars. Roche, under which Genentech operates At the award ceremony last November, as a wholly owned subsidiary, PharmaVOICErecognized two Laurie Cooke, HBA president and CEO, said of its top female leaders as HBA Luminaries: given that women comprise 85% of all cus- dents are female. And this year, Andrea John- Cristin Hubbard, lifecycle leader, Hemlibra, tomer healthcare decisions, organizations such ston, president, W2O pure, has been named an and Sheri Morin, chief purpose officer. To learn as Pfizer, Insigniam, and KPMG have demon- HBA Luminary. more about these fourof outstanding talents as strated how to effectively leverage their in- Both Angela and Casey credit Founder and well as nine of their Rising Star and Luminary ternal initiatives to advance gender parity CEO Jim Weiss for his vision, leadership, and peers from BD, Inovalon, IQVIA, Mallinck- and just as importantly to deliver strategic creating a diverse and inclusive culture. He rodt Pharmaceuticals, Microsoft, Takeda, and business insight. serves on the HBA’s global advisory board Tesaro please turn to the featured profiles Pfizer was recognized for demonstrating an and made a commitment for W2O to join the within this special section. extraordinary drive to unlock the full potential HBA’s Gender Parity Collaborative. of its female talent pool with a portfolio of Genentech, which is also part of the HBA game-changing programs offered through its Collaborative, has an internal women’s net- Recognizing Excellence internal global women’s network. work that was established about a dozen years The HBA’s core purpose is to further the ad- KPMG was selected for championing in- ago. The Genentech Women’s Professional vancement and impact of women in the busi- novative and strategic research that enabled group, or GWP for short, is one of about 20 ness of healthcare, and its mission is to achieve data collection of employee insights around affinity groups the company supports. With gender parity in leadership positions, facilitate the world to enhance its leadership programs. more than 2,000 members, the GWP is one of career and business connections, and provide KPMG used crowdsourcing to identify and the company’s largest ERGs. effective practices that enable organizations to understand diversity and inclusion challenges Carol Wells, senior director, commercial realize the full potential of their female talent. and opportunities to develop relevant, tar- training and development, at Genentech says In addition to its Woman of the Year award geted, and measurable solutions. the company’s focus on developing its women recogition program, since 2007 the association Insigniam was recognized for fostering a leaders was driven from the top. “Years ago our has recognized exemplary leadership initiatives culture of meritocracy that has resulted in CEO Ian Clark establishedCompliments a corporate goal of that advance and enhance the careers of women achieving gender parity in leadership with its having 50% of women at the officer level, and through its ACE (Advancement, Commit- women leaders representing 60% of the com- the company was diligent in applying busi- ment, Engagement) award. pany’s partners and 55% of its consultants. In- nesses strategies to achieve that goal,” she says. In 2019, the HBA ACE Award will recog- signiam has successfully integrated the HBA’s The reason for this focus was simple: women nize internal initiatives that are: accelerating programs as a core component of its company’s make up more than half of the Genentech innovation; driving measurable business re- employee leadership development and is a

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] workforce. While certainly not discounting sults and outcomes; and increasing in reach, model for how small businesses can leverage the importance of other groups, the former scale, and exposure. The organization wel- these programs to develop their women leaders CEO believed it was critical to start with comes applications from public and private and drive business goals.

PharmaVOICE  May 2019 32 HBA Special Feature Ami Simunovich Advancing Equality and the Business

Oftentimes, the legal side of Having good mentors and sponsors has a business is viewed as just helped Ami in her career and she wants to pay functional support for mit- that forward. igating risk. So, for Ami Simunovich, chief “I’ve been able to accelerate my career be- regulatory counsel at BD, her recognition as cause people saw my leadership potential and an HBA Rising Star demonstrates that she and how my unique educational and professional her team are valued for the key role they play background, judgment, and communication in advancing technology in healthcare and that skills positioned me well for certain roles,” her voice is being heard in the decision-mak- she says. ing process. Ami has been at the forefront of advocating Ami says the most exciting part of her job is for women in the industry for some time. She working with leaders to develop time-sensitive founded the Women’s Network at CR Bard, solutions to advance the business. And she which BD acquired in 2018, advocating to combines a unique set of skills in that role as senior management the value that such a net- RISING STAR both a scientist and a lawyer — an invaluable work brings to women and the business. Ami AMI SIMUNOVICH combination as she helps the company navi- is now the global team lead for WIN, working Chief Regulatory Counsel, BD gate complex and changing global regulations. to maximize BD’s sponsorship with the HBA A role model to her colleagues, Ami is active and seeking greater involvement in dedicated For Ami Simunovich, the most in BD’s global women’s network, WIN, and societies to attract more women engineers and exciting part of her job is working works to assist anyone interested in career de- scientists to the company. with senior business leaders to velopment planning. “I try to help others nav- “This year, we’re focused on getting the develop often time-sensitive igate obstacles, such as how to access mentors word out about a better balance of women in or sponsors within the organization, and how the workplace and how to best use a network solutions to advance the business. to position themselves for key roles,” she says. for career development,” shePharmaVOICE says. Elizabeth Woody of A Dealer in Hope

Elizabeth Woody and her “What excites me about my job is being colleagues in public affairs part of critical policy conversations and ele- are making a significant and vating awareness of the company’s ability to meaningful difference to BD. The fact that her address public health needs,” she says. contribution has been acknowledged by the She leads her team as a “dealer in hope,” company earning her recognition as an HBA recognizing that it’s her job as a leader to focus Luminary is, she says, is a reflection of the her team on finding solutions to the challenges LUMINARY strategic value that the organization finds in that the company faces. ELIZABETH WOODY the capabilities of her team.. “It’s about a spirit of optimism and being VP, Public Affairs, BD As VP of public affairs at BD, Elizabeth creative about finding a path forward to solve works to elevate BD’s relationship with policy- problems,” she says. Elizabeth Woody’s focus is on makers — legislators, administration officials, Elizabeth has been part of the formal mentor elevating BD’s profile with professional organizations, patient groups, ac- and sponsor programs at BD. But it’s the in- policymakers at all levels across tually any entity that is setting policy. She formal relationships that resonate. She enjoys healthcare. says through these relationships, the team helping people to think through their work gains insights intoCompliments the market and stakeholder activities, as well as how they can grow their priorities, which allows them to bring these careers, opportunities, and experiences. erything and not get too focused on one area. understandings back into the business. In an organization the size of BD, Elizabeth The more experiences you have, she says, the Public affairs at BD is focused on helping believes it’s important that those mentoring broader your perspective. to shape policies that affect corporate opera- relationships extend outside one’s own func- “What attracted me to BD 10 years ago, was tions, guide public health policies around such tion to garner ideas on how to grow one’s the fact that our products are so fundamental

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] topics as antimicrobial resistance and opioid career in different ways. to the delivery of healthcare that there’s hardly addiction, and enable market access for BD’s Her advice to women starting out or mid- an issue that we don’t care about or can’t help products. way through their career is to try a bit of ev- address,” Elizabeth says.

33 May 2019  PharmaVOICE HBA Special Feature Jennifer Foley Bringing the Right People Together

can bring their full self to work and be com- fortable experimenting, succeeding, failing, and learning together. Jennifer joined Genentech in 2005 as an eing named an HBA Rising Star by intern, and recently moved from the U.S. com- her company Genentech is one of mercial organization to head up a new function B those “wow” moments for Jennifer within global clinical operations as global Foley, who says she is energized to inspire head, business insights and analytics, product others. development. She is focused on late-stage As a servant leader, Jennifer is focused trials. Her team’s challenge is to embed and RISING STAR on helping others succeed. She looks to hire enhance insights and analytics to accelerate smart, curious people with a diverse set of the delivery of these trials to get medicines to skills and experiences. “If I can enable others to patients faster. “We’re in such an interesting JENNIFER FOLEY succeed in some small way, then that’s a good space today with the availability of big data Global Head - Business Insights & life’s work,” Jennifer says. and insights that enable us to make better Analytics, Product Development “I’m always on the look out for those indi- decisions for our trials,” Jennifer says. “Some Clinical Operations, Genentech Inc. viduals who have the mindset to succeed or fail of this entails identifying patient populations with their colleagues for the greater good,” she and picking the right trial sites. It’s also about Jennifer Foley advises women to says. “I love to hire smart people, incredibly bringing consistency and discipline to how we focus on what’s possible and to find capable of course, who are curious, and most forecast and track the performance of our stud- smart, passionate people to work importantly, I like people who want to play ies, clinical programs, and the portfolio and for the name on the front of a jersey and not make adjustments as needed. The benefit that with, because that’s where the magic the back. My role as a leader is to find the right we can provide for patients and for mankind is happens. talent and foster an environment where people astronomical.” PharmaVOICE Saileta Prabhu, Ph.D. of Translating Molecules into Medicines

Her passion for patients began early for Saileta, who grew up in India where 90% of people live in poverty, and she was driven to do something for them. She went to pharmacy aking a people approach to leader- school, then got her Ph.D., and has been work- ship, Saileta Prabhu, Ph.D., is always ing at Genentech for 15 years now. RISING STAR looking for what’s the next best thing There have been many important mentors in T SAILETA PRABHU PH.D. for the organization, her team, and patients. Saileta’s career, who have helped her focus on As senior director of development sciences at truly being there for other people. One piece of Senior Director, Development Genentech, she has a commitment to meeting advice that resonated with Saileta came from a Sciences, Genentech the company’s objective — to deliver new former HBA Rising Star, Dr. Rhona O’Leary, medicines to patients. who said: Saileta, from today onwards, you’re Dr. Saileta Prabhu is inspired by the “My focus on science and patients is my not going to think about ‘I.’ You’re going to dual mission she works toward: doing North Star; it’s entrenched in who I am and think about what you did today to put some- what’s best for patients and doing guides where the people I lead need to go,” she thing on someone else’s résumé that made what’s best for the wonderful team says. Saileta’s role is to help research design the them feel happy and proud. This piece of Compliments she works with. right molecules and start preparing them for advice has been so helpful to me, Saileta says. clinical trials and then to translate what was Saileta is grateful to a culture at Genentech learned in the research and preclinical phase that embraces diversity and inclusion and Fielder, is her inspiration, having seen him for the clinical phase. “I am always thinking is supportive of women, noting such HBA drive major efforts for minorities, under-privi- about how we can push ourselves,” she says. honorees as Dr. Sue Desmond-Hellmann and leged students, and female leaders.

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] “And once we are there, how can we even Jennifer Cook as Women of the Year and Ian Her advice to women is to build your net- push further? What’s the next thing on the Clarke as Mentor of the Year. Her long-time work and relationships with people and push horizon?” manager and mentor at Genentech, Dr. Paul yourself to be the fiercest you can be.

PharmaVOICE  May 2019 34 HBA Special Feature Kaye Kittredge A True Servant Leader

grams such as quality improvement and diversity awareness. “The skills involved naturally RISING STAR translated from helping executives get through their day to helping teams come together and aye Kittredge is a true servant leader. to leverage the specialties they all bring to The most fulfilling aspect of her job achieve something greater,” she says. as a project manager at Inovalon When she first learned she had been recog- Kis the sense of accomplishment she enjoys nized to represent Inovalon as an HBA Rising by removing barriers for people and allowing Star, she was stunned. KAYE KITTREDGE them to do what they do best. “A lot of what I do is behind the scenes,” she Project/Program Manager, Ability Kaye works in the operational excellence says. “I am lucky to work with this excellent Network, an Inovalon company group for Ability Network, an Inovalon com- group of people, so to receive this recognition pany. She joined when the company was is truly an honor. Being part of an organization Kaye Kittredge views herself as a broadening its offerings to include more clin- that connects different sources of information quarterback, leading her team to ical results analysis. She began with helping to improve overall healthcare is really mean- the go-to-market teams consistently roll out ingful work.” success by removing barriers and products, then moved to a more strategic role Drawing on her own experience, the biggest allowing them to do what they do to drive greater operational improvements and piece of advice Kaye has for women who are best. integration. mid-career is don’t be afraid to take time out. A career transformation for Kaye came when Indeed, she did just this to look after her chil- she transitioned from being an executive assis- dren and her aging parents and in-laws. force,” she says. “But people have different tant to being an individual contributor with “It used to be that if you had gaps in your things going on in their lives and your ex- her own projects to run, her own initiatives résumé, you didn’t know how you would perience is embraced when you find the right to complete, and helping to facilitate pro- explain it when you got backPharmaVOICE into the workplace.” of Be inspired.

Compliments Be here. (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]

THE FORUM FOR THE INDUSTRY EXECUTIVE

Half-Page-Print Ads - BeHere Campaign - 032218.indd 5 8/30/18 3:48 PM HBA Special Feature Deepa Desai, M.D. Putting People at the Center

livery network, overseeing close to 3,800 employees worldwide. Today, she manages a relatively smaller but highly impactful team of global professionals handling quality and compliance systems, which boasts of having n her role as VP, global head of quality 70% women team members. management systems at IQVIA, Deepa Managing people in different time zones is Desai, M.D., brings a mix of transforma- not a new experience for Deepa, and while at I LUMINARY tional and democratic leadership to the table. first there were some challenges to work out DEEPA DESAI, M.D. “I believe in being transformational and in terms of process, time zones, etc., she found VP, Global Head of Quality want to be known as a leader to whom col- that technology has helped to bridge many Management Systems leagues come to, when they want positive gaps e.g. by having recorded daily video calls, disruption or a complete change of approach/ ease of data and personnel access, etc. thus IQVIA thought” Deepa says. “I always try to see the enabling her and her team to succeed in the Dr. Deepa Desai finds possibilities possibilities, change the way we do things, do global aspect of the work they are doing. where others believe something things differently. “Having a team located around the world ““I also challenge people to think differently encourages us to think globally,” she says. “It can’t be done by empowering her and I encourage my team to challenge me to exposes us to different ways or approaches, team and challenging them to think think innovatively,” she continues. “I believe opens up new opportunities, and encourages differently. a problem never exists without a solution and innovative thinking,” she says. “At the end thus I empower my team to bring new ideas of the day, although we may come from dif- forward to see how we can overcome problems. ferent cultures and have different ideas, the possibilities” she says. “I believe that as a I also believe that as a team leader I need to emotional intelligence of people is the same leader it’s my responsibility to create more take ownership for whatever the outcome of wherever we come from.” leaders, not only for IQVIA but for the indus- that approach is.” Working for IQVIA, Deepa has been in- try and society.” A true team leader, Deepa always stands up volved with many innovative PharmaVOICEdevelopments. Deepa is sought out as a mentor throughout for and by her team, believing in the motto When IMS Health and Quintiles merged to IQVIA and works closely with emerging fe- “All for one and one for all.” become IQVIA, the team in India recognized male leaders, since this is her passion. that while this brought opportunities, employ- Deepa notes there are several key trends ees had many questionsof regarding the benefit within clinical development, including capa- CREATING ORDER of the merger. “There were a series of various bilities enabled by artificial intelligence and Out of Transformation events organized for employees to celebrate machine learning. But important as these are, the merger, interact with each other, under- they don’t replace the human touch. A physician with a homoeopathy qualifica- stand and appreciate the value of each other’s “Technology today means I can order any- tion by education, Deepa joined the cardiac businesses while recognizing the combined thing from my phone — medicines, food, safety services (CSS) department of what was strength of both,” she says. “We organized travel, etc.” she says. “Technology can take then Quintiles. Under her leadership, CSS activities using various platforms, including us anywhere. But only another human being developed a first-in-kind capability to provide townhalls, an exhibition, a Hackathon, etc. can provide the compassion people need, only 24/7 centralized monitoring of electrocar- which helped create a great impact.” another person can be there to truly listen to diograms for global clinical research studies. someone and help them deal with discomfort Within three years, the organization grew or sadness. The unique quality that human from 10 to more than 60 medical profession- THE HEART beings bring will never be replaced.” als and became the first ISO-certified global of a Physician She believes it is important for every man remote cardiac monitoring or- and woman to pursue interests and passions ganization and set a new global One of the best aspects of the outside of work. “It’s all about the choices standard. job for Deepa is helping patients you make,” Deepa says. “If you can have the “This was back in 2002, and live better lives. That passion for same respect and dedication for your personal it was the first time I un- bringing happiness to people is interests and goals as you have for timelines at derstood the meaningCompliments of the intricately woven into the fact work, you can make them happen.” world being flat because we that Deepa is at heart and soul a Her advice for other women professionals is were working 24/7 and sup- physician. Another aspect of her to take risks and dare to be happy. “Change porting physicians and clinical role that she loves is creating pos- can be scary,” she says. “But if you take on a trial subjects across the world,” sibilities for her colleagues. role with passion, the possibilities are endless.” she says. “One of the best moments for Being named an HBA Luminary is, she says,

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] After a decade transforming me is when someone rec- both an honor and very humbling, but also that business, Deepa moved ognizes his or her own shows her that the contributions she and her into the clinical de- potential and sees the team in India make are valued. RECOMMENDED READING

PharmaVOICE  May 2019 36 HBA Special Feature Natalia Kotchie Connecting the Dots

specific problems that we wanted to solve, and focused on addressing those, which allowed us to align the entire team,” Natalia says. “This was important as we were building this team from the ground up and continuously bring- lthough Natalia Kotchie has predomi- ing new individuals onboard over a two-year RISING STAR nately spent her whole career with one period.” organization, it’s been full of variety. The team’s objective is to help the clinical ASince starting her career with what was then trials industry address its many challenges — IMS Health, Natalia has worked in many dif- from protocol amendments to underperform- NATALIA KOTCHIE ferent functions, with a wide variety of teams, ing sites to patient recruitment difficulties. VP, R&D Applied Data Science Center and in myriad different locations. The first step was to understand the needs and IQVIA Natalia started out with IMS in New York, then identify the capabilities IQVIA could use spent a year in London, worked out of the San to address the goals. Natalia Kotchie leads her team by Francisco office for a while, and four years ago “We asked ourselves what kind of organiza- empowering and supporting them returned to London. tion we needed, how did it need to function, and by being open to different “I always wanted to study or work abroad and how should it interact with the broader and being given the opportunity early in my business?” Natalia notes. creative ideas. career to travel enabled me to learn from teams “With the merger, we saw the promise of operating in different cultures and different data, machine learning, and AI to solve many healthcare environments,” she says. “Having of our challenges,” she continues. “But it’s im- other to come up with a better solution. I look lived in different countries and experienced portant to recognize that great data, analytics, for team members who are able to challenge different systems helps me appreciate the en- and technology must be deployed effectively each other so that we can further our mission.” vironment, opportunities, and challenges each within the trial, with many different functions With many different skill sets and functional region has.” and individuals involved. So, it’s important to backgrounds within her team, Natalia says one Today as VP, R&D Applied Data Science work closely with all of thePharmaVOICE stakeholders who of her biggest leadership abilities is to connect Center, IQVIA, Natalia focuses her team on will be using these capabilities because we’ll the dots of what the team of experts needs to how data science, analytics, and technology only see a positive impact if we make the solu- do to build out the innovative solutions being can be used to transform clinical development. tions work for them.” pursued and provide the needed support for When IMS merged with Quintiles to be- of her teams to achieve their personal and profes- come IQVIA, Natalia started up an analytics sional goals. team dedicated to R&D, initially with four CREATIVE Mentoring is ingrained in the IQVIA cul- people. This group has grown to nearly 200 Problem Solving ture, both formally and informally. Currently, people working across different geographies. Natalia has several formal mentees and says she The teams are comprised of data scientists, Working with a team of people who are pas- loves being a mentor. She has formed a strong solutions experts, software engineers, product sionate about innovating to improve how clin- relationship with her mentees and says she has managers, operational deployment, and go-to- ical trials are done in order to help customers learned a lot from them while also supporting market teams. bring drugs to patients sooner is what makes them in the areas they are seeking to develop. “When I started the team, we identified the the job so enjoyable for Natalia. “These are very bidirectional relationships; I “The best part of my day is seeing the cre- benefit just as much from the mentoring expe- ative ideas that the teams come up rience and supporting others,” she says. “And with to solve problems in new and being in such a big company, the fact that I’m different ways,” she says. “It’s the cre- mentoring individuals from the operations ativity, ability to problem solve, new side of the business gives me exposure to peo- idea generation, and innovative spark ple who I wouldn’t have met had it not been that really excite me.” for IQVIA’s mentoring framework.” Natalia sees her role as a leader being Her advice to women starting out is to listen in part to identify talented individuals and to be open to new ideas. Complimentsand empower them to do their job, while “Healthcare is evolving, and we’ll see a lot of still providing the support they need. “I positive change over the next couple of years, want the team to have a good debate and so there’s much to be learned from different bring different perspectives to the table,” people,” she says. she says. “This is particularly important As for her being named as an HBA Ris- RECOMMENDED READINGas we are always looking to do something ing Star for IQVIA, Natalia describes it as a (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] new. If everyone has the same idea, tremendous honor, not least because of the we won’t necessarily be able to gen- depth of strong and talented women in the erate the innovation or challenge each organization.

37 May 2019  PharmaVOICE HBA Special Feature Melissa Falcone A Positive Focus on the Future

to transformation that led to her honor as an HBA Rising Star. The future of healthcare, she believes, lies in the intersection of technology with patient-centricity. “Mobile apps, telemedicine, elissa Falcone believes in looking to and wearables impact our ability to help pa- the future — for her team, her com- tients manage their disease and also provide RISING STAR M pany, and the patients Mallinckrodt a huge amount of data that can be analyzed MELISSA FALCONE serves. In the seven years she has been at the through AI to help us further advance our VP, Patient Services and company, she has seen a huge transformation knowledge of disease areas and evolve our in its patient engagement model. products to serve patients’ unmet needs,” she Reimbursement, Mallinckrodt As VP of patient services and reimburse- says. “I see my team’s function as a very im- Pharmaceuticals ment, Melissa was given full autonomy to portant one within the company, and I think deliver on the goal of adding value to patients that we are the nexus point for patient-centric- Melissa Falcone looks to the future with high unmet needs. ity and taking care of people to get them to a and the opportunity to leverage “My team and I have a mindset of contin- better outcome with their healthcare.” technology to drive patient-centricity. uous improvement,” she says. “We’re always Over her 18-year career, Melissa credits thinking about what more can we do to pos- the mentors she has had along the way who itively impact patients, their experience with encouraged her to take risks. In turn, she seeks represents opportunity. “I keep the dragon as our company, and innovative ways we can con- to mentor those who are motivated and pas- a symbol to remind me to stay focused on the tinue to raise the bar of our service to them.” sionate about what they do or who simply may future for myself, my team, my company, and A believer in a shared vision for the future, need help to build their confidence. patients,” she says. “I feel very empowered Melissa works to create alignment around Her focus on creating opportunity is well re- here. I believe the sky is the limit in terms of that vision and then empowers her team to flected in her choice of office decorations: a tiny what my team’s contribution to our patient do what they do best. It’s this commitment ceramic dragon, given to her byPharmaVOICE a former boss, population can be.” Kathy Schaefer of Leading Through Change

their own thing, providing ongoing two-way communications, and giving her reports what they each need when they need it. “Some people need more guidance, some need less,” she LUMINARY says. “You have to get to know your people, wenty-five years may seem like a long and then understand what their needs are. I time to be with an organization, but have an excellent staff who do a good job and when it’s one that has been through who are eager to make work more enjoyable for Tmany transformations, there’s no chance of our extended team.” KATHY SCHAEFER becoming complacent. As senior VP finance, Within her team, she takes a people-fo- SVP Finance, Corporate Controller, corporate controller, for Mallinckrodt, Kathy cused approach to work-life balance by cre- Mallinckrodt Pharmaceuticals Schaefer has guided her team through many ating a fun, collaborative atmosphere. She changes, which keeps her people highly moti- encourages an open environment where peo- Kathy Schaefer says to be successful, vated. She stays focused on setting the course ple work in their own areas as well as across one needs to be flexible and know and building the company’sCompliments values and repu- cross-functional projects. how to navigate through challenges. tation amid acquisitions, spin-offs, and other Kathy has been a formal mentor within the changes that affect the business. company in the past, but today she guides “We have to be flexible as we navigate people informally both within her direct group on a cross-functional project, or serve on an through various challenges,” Kathy says. “Be- and beyond. She advises people to demonstrate inclusion and diversity team. She is active in cause of all the different transactions and vari- their value to the company by doing a good HBA as well as with the company’s Women

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] ety of work my team has been doing, they are job, after which their voice will be taken more in Business ERG, and she serves as Mallinck- gaining a great deal of experience.” seriously, and to step up and get involved, rodt’s representative for Women in Business Kathy leads by enabling her reports to do e.g., address a resource shortfall, participate for the St. Louis area.

PharmaVOICE  May 2019 38 HBA Special Feature Brenda Fix Collaboration and Communication: Keys to Good Marketing

possible rare diseases to help speed diagnosis.” In February, the Commission put forward its recommendations that map to three solution pathways: empowering patients and families, here are two words that sum up equipping frontline providers, and empower- Brenda Fix’s leadership style: communi- ing patients and families. There are more than Tcation and collaboration. This is because 6,000 identified rare diseases, the vast majority of her personality and the nature of her role as of which begin in childhood, with patients LUMINARY senior marketing manager, US health and life receiving a misdiagnosis more than once in sciences, at Microsoft, where she works with 40% of cases. Brenda believes AI, when used people from different parts of the business securely and ethically with unbiased data, can who have different goals and different ways help customers find ways to solve their biggest BRENDA FIX of thinking. “I’ve spent my career managing business and clinical challenges. Senior Marketing Manager, U.S. teams and projects with diverse internal and “Meeting customers and learning how they Health and Life Sciences, Microsoft external stakeholders,” she says. “Working use our tools to improve the lives of patients with V-teams, or virtual teams, I run proj- is the best part of my job,” she says. “I al- Brenda Fix leads her team with a ects with C-suite, marketing, development, ways learn something new when I talk with commitment to collaboration, noting partner, and customer team members. These customers, and collegues. We have a great learning happens when you reach individuals think differently, so it’s important network of people and they contribute not just out and gather insights from other as marketers to to listen to their project goals to what I’m doing, but to the overall project. and learn what their business problems are.” Collaborating is a great way to learn and make people. Brenda notes that while the IT industry new connections.” in general falls short of hiring women at PharmaVOICE the same rate as men, she is seeing more “Remember that you define your success,” high-quality, talented, and diverse women Charting a she says. “Climbing the ladder to management joining the marketing organization. Path to the Top or the C-suite is just one path. Mid-career “I focus on the positive, that we have tal- of women have a lot of tribal knowledge and ented women on staff. I mentor and develop Brenda has a vast knowledge of healthcare experience. They don’t have to be a manager, them, alert them to opportunities, and educate IT. She joined Microsoft five-plus years ago, director, or executive to have a rewarding ca- them on other disciplines in the company,” she after a fulfilling career at Quest Diagnostics reer. They need to be recognized for the value says. “We want women to understand and and Siemens Healthcare. She enjoys start-up they bring to the organization.” develop their strengths and see how far they projects and working in an entrepreneurial Brenda knows first-hand that a fulfilling ca- can go with their careers.” mode. She started her health IT marketing career doesn’t always follow a straight line from Brenda says she loves getting to meet dif- reer by joining CareScience, an Internet-based, point A to point B. ferent people from within Microsoft and her risk-adjusted outcomes tool in the mid-1990s. “I’ve been in healthcare for 30 years,” customers, and learning about their break- “I’ve been watching healthcare IT for a long Brenda says. “I started out as an English writ- through projects. For example, while working time, and while there are women in the field, ing major, working at Pittsburgh Magazine. with Takeda (a customer) and a colleague, and more coming in, there is still a lot of work I then went into medical publishing. I never she learned about the Global Commission to to be done to get them a seat at the table.” Her would have guessed that I would be leading End the Diagnostic Odyssey for Children (the advice for women entering the workforce is to health marketing at Microsoft. My advice is Global Commission). Takeda, talk to people and ask lots of to follow your interests and don’t be so wed to Microsoft, and EURORDIS-Rare questions ,because most people what you or others think you should be doing, Diseases Europe are co-chairs of want to help others gain new because you may find something that’s even this alliance of more than 800 rare insights or knowledge. more interesting.” disease patient organizations. At the mid-career point, Brenda recognizes that work-life balance for “We’re using Complimentsour tech platform Brenda says women should be women is tricky and having been a working to help clinicians find the needle open and willing to take new mom with two daughters, now 20 and 25, in a haystack when diagnosing paths from where they started. she knows the pros and cons of trying to do rare disease,” she says. “One of This may be a senior role or it all and still be a role model to her children. my colleagues in Spain devel- it might a position in another She also notes that her husband has always oped a cloud-based AI and ma- area of the company. The supported her career. “I want my kids to know

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] chine learning tool that analyzes bottom-line she says is they can have a good career and be a parent patients’ genetic material and to be open to oppor- and they don’t need to be a CEO to be suc- offers clinicians a list of tunity. cessful.” RECOMMENDED READING

39 May 2019  PharmaVOICE HBA Special Feature Cristin Hubbard Working Toward Healthcare Advances

Growing up as the youngest — all of which resulted in her being named daughter of a nurse, the de- an HBA Luminary by Roche. sire to help patients was “The priority is to believe in yourself — to strong for Cristin Hubbard. bring your authentic self and your creative She considered being a doctor ideas to the table, and to not be afraid to but was drawn to drug discovery as a medic- voice them,” she says. “We all have a different LUMINARY inal chemist and later pursued public health way of looking at issues, and both research and the business side of drug development and my own limited experience have shown and commercialization, all of which encom- that if those diverse perspectives are heard pass a 20-year career in healthcare. and considered, it will benefit the team, deci- “I wanted to be more closely involved in sion-making, and the overall outcome.” CRISTIN HUBBARD getting medicines to patients,” she says of She believes when evaluating risks it’s Lifecycle Leader, Hemlibra, Roche her career path. important to remove the personal element — Today, as lifecycle leader for Hemlibra, meaning the impact on one’s career — which Cristin Hubbard is helping to Roche’s breakthrough treatment for hemo- then allows leaders to be more courageous lead Roche’s transformation and philia A, this is precisely what Cristin is and bold to do what’s right for the patient empowering small teams to drive the doing, acting as the de facto CEO of the community being served and for the people business forward. molecule. within the organization. “It’s been rewarding to take this transfor- “If I can unlock the true potential behind mational medicine that can benefit patients every person who is sitting around the table, what she learned from her own mentors to market by not only building the trust that then I’ve done my job as a leader by empow- throughout her career. is important for the hemophilia community, ering the team to make bold decisions, which “I’ve been fortunate to have had phenom- but also thinking uniquely about how to can lead to incredible outcomes in the end,” enal mentors and sponsors along the way, get Hemlibra to patients in all parts of the Cristin says. including Jennifer Cook who was the HBA world,” she says. She uses her own experiences to talk to Woman of the Year in 2016,” she says. “She Cristin leads her team with a focus on younger women who have notPharmaVOICE yet built up and others showed more belief in me than authenticity, transparency, courage in deci- that self-belief. I did in myself in those early years, which sion-making, and inclusion of different views For Cristin, it’s alsoof about paying forward helped me to find my authentic voice.” Sheri Morin Sparking Change

It’s a huge honor to be named ness and the industry to engage with others an HBA Luminary. For Sheri to seek new ways of working. She advises Morin, on one hand it shows others — whether starting out or mid-ca- that her impact on the organi- reer — to be curious and seek new ways to zation is recognized, on the other she sees it as stretch oneself outside of their comfort zone. a responsibility to contribute more to inspire “I learned early in my career that if I was LUMINARY change throughout the company. in a rut or not feeling a sense of purpose to Sheri is chief purpose officer and general find ways to address change, through mentors manager in the Netherlands for Roche, where or changing the scope of my work,” she says. she has been instrumental in the transfor- “I’ve always been a strong believer in not mation of the business. She describes her job settling.” SHERI MORIN as one of servant leadershipCompliments — ensuring the Sheri’s purpose is clearly to have an impact, Chief Purpose Officer, Roche organization and its employees are empowered while helping others succeed to levels they and have the right level of support and the may not have thought possible. Sheri Morin ensures her staff and the right networks to successfully deliver for the In her office, she keeps a photo of a group organization have the right level of patient. The best part of her job, Sheri says, is of healthcare workers in Tanzania taken support to successfully deliver on being the spark to help others figure out how when she led a group from Roche to enable their North Star vision, “doing now (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] to take a leap and put their ideas into practice. the local Tanzanian team to improve cancer what patients need next.” Inspiration comes from many different care in their region, to remind herself of the sources, and Sheri goes outside of the busi- change that one person can make.

PharmaVOICE  May 2019 40 HBA Special Feature Meena Subramanyam Focused on Patient Needs

With an eye on the future, she says her job allows her to develop unique strategies to advance Takeda’s GI therapeutic assets and LUMINARY work with a multifunctional team to translate n her role as VP and global program lead, those strategies into clinical practice. “We GI therapeutic area unit at Takeda Phar- want to be transformational and create better I maceuticals, Meena Subramanyam pushes medicines for a brighter future,” she says. MEENA SUBRAMANYAM her team to test past assumptions based on “We interact with patients and caregivers VP and Global Program Lead, GI evolving scientific and technical data, and to understand their issues from early symp- Therapeutic Area Unit, Takeda urges critical scientific thinking to eschew toms to disease diagnosis and then develop Pharmaceuticals preconceived notions. “I encourage a culture therapeutic strategies to make a meaningful where people feel empowered to voice diverse difference to patients.” Meena Subramanyam advises opinions and take informed risks,” she says. Meena is not only a mentor to those she professional women to be authentic, Having been part of previous teams that leads but to high school and college students remain curious, ask for help, and be have brought eight medicines to market, a embarking on STEM careers. “I’m also a key part of Meena’s current role is helping board member of Women in the Enterprise adaptable to change. Takeda successfully manage through not only of Science and Technology in Boston, which the regulatory process but substantiate the empowers women in science to achieve their value of medicine to patients, physicians, and full potential,” she says. “I see mentoring Luminary, Meena says, is gratifying while payers. “AI-driven digital solutions and wear- as part of my responsibility, having been in also creating a deep sense of responsibility to able devices will play a key role in demon- this industry for more than 20 years I have continue to model good leadership behaviors strating the value of scientific innovation to the privilege of knowing many people. I like and help others advance their careers. One patient benefit, and in improving preventive to help people find career opportunities and key piece of advice to fellow female profes- care through increased patient engagement,” build their professional network.” sionals she offers is to focus on strengths she says. The recognition from TakedaPharmaVOICE as an HBA rather than weaknesses. Amy Sullivan of Reaching Across Borders

she has signed up as a LinkedIn volunteer, and is currently helping a young administra- tive assistant grow her career. One key piece of advice she offers to others is to seek oppor- eading as a coach and connector, Amy tunities to gain the skills and experiences re- Sullivan encourages her teams to expand quired before going after the next promotion. L their networks and connections in the “If you want to manage people, find some- RISING STAR quest to help them move forward in their one to mentor, or offer to train and sup- careers. It’s an approach she has taken in her port a new hire,” she says. “At Takeda, we own career and embedded in her role as head have many ERGs, including Our Women at AMY SULLIVAN of talent management at Takeda Pharmaceu- Takeda group. This is another opportunity Head of Talent Management, ticals. Mentorship is integral to talent build- for people to gain leadership experience.” ing. As such, as part of Amy’s remit, her team When considering the right talent to bring Takeda Pharmaceuticals manages early talent programs, coaching on board, Amy says it’s important to look at Amy Sullivan sits in a unique position people joining the organization straight from changes affecting the business and the indus- within Takeda, helping to guide talent college and puttingCompliments them in three-year rota- try in general. The industry has gone through tion programs to gain different experiences. many mergers and acquisitions so she says across the business to identify new “We pair each of the employees with it’s important to hire and grow leaders who opportunities. an on-boarding buddy who is more of a can navigate through the ambiguity and un- peer-mentor as well as with someone outside of certainty change can create. Takeda’s recent their line function to help them transfer from acquisition of Shire is a case in point. cross-cultural training and coaching and rota-

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] campus to corporate life,” she says. Globalization is another key opportu- tion experiences that help our people to work Beyond Takeda, Amy also mentors people nity for the industry.“We build our leader- across borders and leverage the diverse talents looking to progress their career. For example, ship programs with this in mind, offering across the globe,” she says.

41 May 2019  PharmaVOICE HBA Special Feature Kristin Ainsworth Guiding Women to Opportunities

that getting an opportunity to do what she didn’t think was possible, was possible, that was really neat. Mentorship has been integral to Kristin’s career — both giving and receiving. While she here’s no bigger critic of your work didn’t have formal mentors, there were always than yourself, says Kristin Ainsworth, individuals who she would go to with ques- TVP of corporate affairs, PR advocacy and tions about her career as well as business issues. communications, at Tesaro. And she knows “All I know is to be myself and to be avail- this is particularly true with women, where able and to be present with the individuals on voices of self-doubt can be powerful. my team, individuals throughout the organi- LUMINARY “I have found that if your inner critic is zation, and with individuals throughout the telling you something might be possible, then industry,” she says. “I think there’s also a big you’ve already leapt over the biggest hurdle,” lesson in being authentic. We shouldn’t feel KRISTIN AINSWORTH she says. “If we all took the opportunity to be pressure to be someone we’re not. My advice is VP, Corporate Affairs, PR Advocacy and risk takers and didn’t let doubt get in the way, just be yourself and folks will seek you out for Communications, Tesaro imagine where we could be.” advice and guidance.” As a mentor and a leader, Kristin is com- The personal is important to Kristin. In- As a mentor and leader, Kristin mitted to supporting colleagues through every deed, the item in the office she most values is Ainsworth is committed to challenge. In fact, she describes this as the best a letter from her 7-year-old daughter written supporting colleagues through a part of her job. while she was away on a business trip. It says “I mentor a number of people in Tesaro and simply: “Mommy I’m sorry you had to be challenge and describes it as the best we meet regularly, usually outside the office, gone for a day, I missed you so much.” Kristin part of her job. to talk about any number of topics — from hangs that letter in her office as a reminder to professional, to personal, to community,” she put family first and be very thoughtful before says. booking that airplane or train ticket.PharmaVOICEwith advanced ovarian cancer in general. It’s “Because time is so precious, I always weigh a wonderful opportunity to help these women if attending a meeting will add value or would connect with others living with this disease.” BEING AVAILABLE my time be better spent at home with my It’s all part of a big trend, in which pharma and Present kids,” she says. of is finding new ways to reach more people in the healthcare space, Kristin says. “It’s about Kristin is honored and humbled to have meeting people where they are and in ways been named an HBA Luminary by her col- GIVING BACK that are accessible 24/7 to give people the ap- leagues and peers. For her, being a role model and Paying it Forward propriate information to make good healthcare is about being available and present with the decisions.” people on her team and being authentic in Today, Kristin more than gives back to everything she does. the industry — both within Tesaro and as an She describes herself as a situational leader, HBA member. BLAZING basing her management style on the principles As a leader in PR advocacy and communica- A New Trail of understanding who the individuals are on tions, Kristin has been at the forefront of big the team, meeting them where they are in changes in patient outreach. Because pharma Kristin and her company have deep con- their career journey, and un- is so heavily regulated it has been nections to the HBA in the Boston region. In derstanding how much direc- slow to embrace social media. 2018, Kristin was nominated to be a member tion and support they need to But that has changed. of the first Executive Exchange (https://www. achieve their goals. “We’re doing a better job rec- hbanet.org/executive-exchange) program, “Just recently, I met with a ognizing the good that can come which brings together senior-level members teammate who had talked her- from setting up appropriate chan- in the industry to give them an opportunity self out of raising her hand for nels to organize communities of to explore new leadership opportunities. A an opportunity in theCompliments company patients,” she says. “For example, key objective is to help women at the C-suite, because she just didn’t feel she our company is heavily invested VP, and executive VP levels gain new insights was ready for it,” Kristin says. in helping women with advanced and address problems related to gender parity, “And as we sat and talked ovarian cancer have better con- diversity, and inclusion. about all the reasons why that versations with their healthcare “The program is now in its second year, and was and wasn’t the case, I professionals about the it’s been a tremendous success,” she says. “I

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] watched her gain confidence disease treatment op- was honored not only to be nominated for the in herself, and come tions, side effects of program but to participate in the inaugural to the understanding treatment, and living year.” RECOMMENDED READING

PharmaVOICE  May 2019 42 HBA Special Feature

The HBA’s 2019 Rising Stars and Luminaries provide their insights on the trends they are tracking that they believe will impact the Trend Tracking industry in the coming years.

Artificial Intelligence patients self-manage, and insurers reimburse Hiding within those mountains of data are in the next few years. answers and knowledge that could change the Apoorva Aggarwal — Rising lives of patients, or change the world. Organi- Star Meena Subramanyam, Ph.D. — zations that are passionate and committed to Principal, ZS Associates Luminary applying data intelligence to extract new and AI in pharma is exploding as VP and Global Program Leader, valuable insights will be the leaders who create care and decision making begin Takeda Pharmaceuticals the future value that others miss. to shift from a human model to a human-ma- Real-world evidence generated chine collaboration model. by wearable devices and other AI-driven dig- Jennifer McGee — Luminary ital solutions will have a major impact on the VP and Chief Compliance Officer, Lily Dobberteen — Rising Star future of healthcare and will be critical not Otsuka America Pharmaceutical Project Operations Specialist, only to translate the value of scientific inno- Increasing proliferation of data AiCure vation to patient benefit, but also to improve allows for better-educated con- The trend that will most impact preventive care through increased patient en- sumers and enables providers to use AI in healthcare is personalized medi- gagement. diagnosis and treatment. This data is a dou- cine, the use of advances in genomic analysis, ble-edged sword, with significant privacy and and artificial intelligence to inform individu- Connectivity ethical considerations to safeguard its use. alized care. Shannon Gath — Rising Star Iramis Ralat — Rising Star Tara Fitzgerald — Luminary VP, Head of Technology, AMAG Director, OSD Manufacturing President, Clinical Development Pharmaceuticals Operations, Bristol-Myers Squibb Services, Robust networked healthcare The broader use of real-world Syneos Health ecosystems that will connect pa- data will lead to a deeper under- We have, and will continue to tients, clinicians, caregivers, and payers more standing of the impact of the different thera- see, an increase in AI research, including ma- directly will lead to opportunitiesPharmaVOICE to deliver pies beyond the clinical trials to influence the chine learning and manual task automation. more affordable and convenient quality care. market access of medicines in the future. As the industry responds to get drugs to market faster, we will need to embrace change Costs Drug Pricing when it comes to clinical trial execution. of Divya Annamraju — Luminary Andrea Johnston — Luminary Brenda McGuirk Fix — Deputy Director, Strategy President, W2O pure, W2O Group Luminary Medical Devices Product Supply, As clinical development contin- Senior Marketing Manager, U.S. Bayer U.S. ues its rapid pace of innovation, Health and Life Sciences, Microsoft With increasing income inequal- payer and pricing models must AI, when used ethically, securely, ity and rising healthcare costs, finding ways to evolve to enable potentially curative therapies and without bias, can solve business problems, make quality healthcare accessible in a fiscally to be delivered to patients. speed drug discovery, personalize patient care, sustainable manner is more important than and unlock new diagnoses and treatments. ever. The healthcare industry has the potential Madhuri Shah — Rising Star to develop breakthrough solutions across the Brand Lead, Rexulti, Lundbeck Natalia Kotchie — Rising Star full healthcare delivery continuum, which will The trend that I believe will have VP, R&D Applied Data Science ultimately benefit patients and communities the biggest impact is increased Center, IQVIA alike for years to come. drug pricing. I don’t think the Where AI enhances human deci- industry will be able to sustain the magnitude sion-making, augmented intelli- Leann Pezdirtz — Luminary of yearly price increases, however, not taking gence will transform drug development and Head, Field Based Medicine, the price increases may have a negative impact overcome long-standing challenges. However Boehringer Ingelheim on innovation and investment in R&D. It will commitment to change is required to realize The vertical integration of be critical to find the right balance. the benefits. Complimentshealthcare from payer to PBM to provider will continue to be a trend. Health Outcomes Charmain Piotrowsky — Rising Star Data Intelligence Elizabeth Davies — Rising Star Regional Business Director, NYC, Senior Director, Brand Payer Novo Nordisk Ellie He — Rising Star Marketing, U.S. Pharmaceuticals,

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] I believe that AI and the utiliza- Director, Head of Biometrics, GSK tion of digital technology will have the great- Imbrium Therapeutics, a Recent payer-PBM mergers and est impact on how healthcare providers treat, subsidiary of Purdue Pharma increasing real-time data integration will

43 May 2019  PharmaVOICE Congratulations to Andrea Johnston for receiving a Healthcare Businesswomen’s Association Luminary Award

PharmaVOICE of

The HBA Luminary award recognizes female leaders who actively mentor and sponsor others, help advance other women’s careers, and demonstrate dedication to the healthcare industry. Andrea is a shining example of this, and we couldCompliments not be prouder. Congratulations! (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]

w2ogroup.com

W2O1914_Andrea_Johnston_Ad_M01v3.indd 1 4/16/19 11:52 AM HBA Special Feature

allow for a more holistic examination across that healthcare is not one-size-fits-all, but People have been exposed to digital inno- pharmacy and medical costs and associated we are seeing more and more approaches to vation in healthcare for several years now. health outcomes. deliver healthcare that meets the needs of in- They understand how to best use these dividuals. Whether it’s how we innovate to advances for their health and well-being. Kelly Hornsby-Clawson — find solutions or leveraging technology and Rising Star learning to serve people the way they need to Michele Wylie — Rising Star Director, Customer Support, Roche be served, the future is exciting. Associate Director - Market Access Diabetes Care Operations, Novo Nordisk As Americans gain more interest Kathi Henson — Luminary The healthcare industry will con- and control over their health, pressure will President, Patient Services, tinue to evolve to a patient-cen- continue to increase on the costs associated Eversana tric design perspective model and find ways with healthcare and the resulting health out- Patient-centric innovations in ed- to partner more often within the industry to comes. ucation and technology will be bring expertise and creativity together within important as the payer landscape drives focus business models to readily create more solu- Liz Paulson — Luminary on demonstrating improved health outcomes. tions for the patient. Strategic Account Executive, LexisNexis Risk Solutions Kaye Kittredge — Rising Star Preventive Care Social determinants of health Project/Program Manager, Ability provide a complete picture of pa- Network, an Inovalon company Kristin Ainsworth — Luminary tients and the nonmedical factors influencing Patient consumerism is a big VP, Corporate Affairs, PR Advocacy their health that if addressed proactively can trend. At its core, healthcare and Communications, Tesaro improve outcomes. needs to make people’s lives better through We’re finding ways to reach access and price transparency for patients, more people in the healthcare Patient-Centricity and data and ease-of-use for providers, and out- space outside of traditional ways, meaning Personalized Health come-based accountability. a rep to a doctor. It’s about meeting people where they are and meeting them in ways Erin Byrczek — Luminary Jennifer Korngut — Rising Star that are accessible 24/7, whether that’s VP, U.S. Brands, Pfizer Account Supervisor, Havas Health + online, digital platforms, radio, or TV. It’s In a fragmented and increasingly Patient engagement through au- about putting our information appropriately digitized healthcare landscape, tomation is a big trend. Just this in the hands of people so they can make changing patients’ lives by em- week, we sawPharmaVOICE Amazon launch good healthcare decisions in ways that are powering them with personalized, need-meet- HIPAA-compliant healthcare skills for Alexa. not just so traditional anymore. ing resources will have the biggest impact. Sheriof Morin — Luminary Bridget Mabey — Rising Star Michele Irwin Cunningham — Chief Purpose Officer/General Associate Creative Director, Ogilvy Rising Star Manager, Roche Health VP, Commercial Operations, We need to increase our efforts Consumers are becoming more Strongbridge Biopharma around personalized healthcare, educated about their own wellness The voice of the patient continues truly delivering the right medicine and solu- and steps they can take to prevent chronic ill- to be elevated in healthcare. This is especially tions to the right patients at the right time. ness. This is a great opportunity for investment true in rare diseases, where connecting patients in new technologies that help keep people to share their experiences, and amplifying the Catherine Owen — Luminary healthy, both physically and mentally. patient voice for the physician audience, can President, Janssen Immunology at foster better understanding of the unique jour- Johnson & Johnson Sarah Mooiweer — Rising Star neys and challenges faced. Patients’ experience, and their abil- Account Supervisor, TBWA\ ity to make a more informed choice WorldHealth Kari Delahunty — Rising Star in their own healthcare journey, continues to be a People are proactively seeking in- Senior VP, Corporate Strategy, trend that we need to embrace further. formation about their health to Syneos Health inform preventive treatments. What can we One of the biggest challenges LeAnne Walstra — Rising Star build on between genetic testing and custom- facing the healthcare industry is Group VP, Client Services, The ized vitamin packs to green juice and spinning? the consumerization of healthcare. We must Lockwood Group improve customer (e.g., HCPs, physician, GP) On-demand patient care bringing Policy and Regulations engagement andCompliments patient satisfaction by adopt- medical professionals to patients ing a consumer-centric model that drives value wherever they are, whenever they need it, Alexandra Bauer — Rising Star for all stakeholders, specifically the patient. through online and telemedicine services, will Account Director, Calcium USA radically transform healthcare. Healthcare policy makers and Allyson Funk — Rising Star payers are increasingly dictating Head of U.S. Communications and Jenny Woodward — Rising Star which drugs HCPs can prescribe,

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] Public Affairs, UCB VP, Group Art Supervisor, TBWA\ which limits HCP’s prescribing power. There has long been recognition WorldHealth

45 May 2019  PharmaVOICE TWO STARS ARE BORN.

Congratulations Sarah Mooiweer and Jenny Woodward on winning the HBA’s Rising Stars Award. PharmaVOICE

You defy convention, of disrupt the norm, and bring out the best in us every day. Shine on!

Compliments (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]

PharmaVOICE  May 2019 46 HBA Special Feature

Kathy Schaefer — Luminary Deepa Desai, M.D. — Luminary Kelly Lenahan — Rising Star Senior VP Finance, Corporate VP, Quality Assurance, IQVIA Manager, Scientific and Health Controller, Mallinckrodt We are in an interesting time Policy Initiatives, ISPOR—The Pharmaceuticals of transformation: AI and ma- Professional Society for Health There are many things going chine learning vs. physicians and Economics and Outcomes Research on in the government affecting our business, human touch. Consumers ask for seamless, I believe that more personalized gene, CAR- whether it’s regulations around opioids, or just-in-time, accurate information to make T, and curative therapies will have the most price discussions for branded drugs. We have accurate decisions via DIY (mobile) technol- impact on healthcare in the future. These are to be flexible and know how to navigate ogy vs. clinical. Thus for me, the No. 1 trend treatments that are important to patients and through these challenges. would be scientific innovation, from genom- improving healthcare, yet play a huge burden ics studies to assess risk and prevent disease on the budgets of healthcare systems and payers. Ami Simunovich — Rising Star proactively to exploring virtual surgeries via Chief Regulatory Counsel, BD 3D bioprinting technology or AI-based de- Candice Lenkowsky — The changing global laws, reg- vices for accurate diagnosis. Using blockchain Luminary ulation, and enforcement on de- and data science, algorithms can be created Head, US Immunoscience Sales, vices will have the biggest impact to test chemical and biological interactions, Bristol-Myers Squibb on healthcare. Compliance enforcement will which are more safe and accurate. This can Precision medicine has changed shape how we get affordable disruptive tech- help pharmaceutical R&D to bring effective treatment approach in cancer and is rapidly nologies to global markets. medicines to market faster and cheaper. expanding to other areas such as rheumatoid arthritis and multiple sclerosis. Elizabeth Woody — Luminary Elena Herrero — Rising Star VP, Public Affairs, BD Group Art Supervisor, Evoke Giant Stephanie Tanck — Rising Star When I think about policy mak- During the past few years, scien- Associate Product Manager, Ortho ers I think about that term very tific, medical, and technological Clinical Diagnostics broadly to include legislators, advances have ushered in a rev- Agile diagnostic solutions are administration officials, provider groups, pro- olutionary new era of immunotherapy. It is needed to better address global fessional societies, patient groups, any entity my hope that tailoring immunotherapy to the clinical needs driven by changing lifestyles, that’s setting policy, a guideline or a regula- specific microenvironment of each patient’s ranging from infectious disease and diabetes tion or legislation. They all have an impact on tumor will become the new standard of care for in emerging markets, to fertility and drugs of our ability to be successful. cancer treatment. This, combined with com- abuse in developed markets. puter-aided prediction usingPharmaVOICE AI, holds great Scientific Innovation promise for shaping the future of healthcare. Daniela Vernille — Rising Star Director of Logistics Solutions and Róisín Armstrong, Ph.S. — Jannaof Hutz — Rising Star Compliance, Pfizer Luminary Senior Director and Head, Data Access to innovative oncology VP, Soliris Medicine Team Leader, Science & Scientific Infrastructure, medicines in emerging markets Alexion Eisai is a big problem and we need to remain Scientific breakthroughs will de- Working with so many talented committed to work collaboratively to liver increasingly innovative, life-changing data scientists, I think the growth of human ensure patients have access to life-saving rare-disease medicines. It’s the shared respon- biology data and the enthusiasm around it will medicines. sibility of all stakeholders to work together so lead to meaningful impact. patients benefit from these breakthroughs. Talent Management Vera Imper, Ph.D. — Luminary Tiffany Chen, Ph.D. — Rising VP and Head of Business Tracey Morrison — Rising Star Star Development, Roche Molecular Director Human Resources, UCB Directory, Discovery, Rubius Solutions Finding the right talent/ Therapeutics I believe precision diagnostics employee who has a Cell and gene therapy are rapidly will transform patient care by delivering high- multidisciplinary skillset that emerging as potentially curative treatments for value clinical insights and optimizing medical compliments the complexity of the healthcare the most challenging diseases. We are on the decision-making. industry is a growing trend. Why? Because cusp of a medical revolution. the evolution and transformation of the Danielle King — Rising Star industry mindset is shifting from tactical to Nicole Crawford — Rising Star Account Service, Fingerpaint strategic ways of engagement. Talent is more ExecutiveCompliments Business Director, Solid With the rise of 23&Me and diverse and agile. Our challenge will be to Tumor Northeast Region, Novartis therapies such as CAR-T, pa- find this talent and even more challenging Oncology tients will demand, and for the will be how we retain this talent given the We are fortunate enough to be at first time be able to receive, truly person- need for the more multidimensional skill set. a precipice of science with major advancements alized treatment at the genetic level across that offer patients a potential cure rather than their care team.

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] chronic treatment and this will undoubtedly disrupt the healthcare industry.

47 May 2019  PharmaVOICE HBA Special Feature

Technology and Advanced Analytics vance our knowledge of disease areas, evolve by the development of digital and therapeutic our technology, and advance our products to innovation. We are witnessing disruption in Cori McKeever Ashford — serve their unmet needs. digital technologies and advancements in ther- Rising Star apies that will require enhanced coordination Executive VP, Healthcare Practice Beatriz Faro — Luminary and integration across functions and channels. Lead, Central Geo, Weber Regional President IDM IM, Pfizer Shandwick Predictive analytics and big data Catharina (Candy) Lurken — Technology will continue to transform health- will change everything from Luminary care, but only as far as our ability to articulate its R&D to manufacturing to com- Principal, Deloitte Consulting LLP human impact on patients, providers, and payers. mercialization of drugs, allowing for more Digital health transformation, personalized treatments. which is being driven by strong Domenica Askeland — Rising market signals related to data as the new Star Adriana Fernandez — Rising healthcare currency, evolving patient expecta- VP, Global HR Operations, Pfizer Star tions, and standards supporting data exchange, Leveraging technology and am- Senior IT Director, Manufacturing show a path for transformation toward driving plifying digital efforts will power and Quality, Eli Lilly outcomes through a more connected patient us to discover and identify preventive treat- The Internet of Things, data, and ecosystem. ments faster for our patients and improve our the ability to connect devices to patients and overall productivity. healthcare providers will provide the ability Cathy Skala — Luminary to have highly personalized consumer-centric VP, Business Transformation Office, Sarah Bast — Rising Star health. In addition, the power of information Baxter International Group VP, Media, Publicis Health exchange will allow for the continuing discov- I anticipate breakthroughs Over the last decade, technology ery of new solutions for patients. in managing patients’ health and mass digitization have trans- through data analytics. Just imagine being formed possibilities for health- Jennifer Foley — Rising Star able to develop treatment options with science, care marketing across the board, with point of Global Head - Business Insights & data, and artificial intelligence combined. care emerging as one of the most intriguing Analytics, Product Development and exciting channels. Marketers must em- Clinical Operations, Genentech Heather Zigmund — Rising Star brace a new strategy for targeting in the POC Our increasing ability to unlock Senior Director, Head of channel — one that uses diverse datasets and big data through advanced analytics is signifi- Clinical Services, AstraZeneca algorithmic learning to define target audiences cantly evolving healthcare — fromPharmaVOICE enabling us Pharmaceuticals based on a much broader set of criteria. to more readily predict disease and intervene New technology developments earlier for better patient outcomes to speed- will give us the tools to unleash the power Terentia Browne — Rising Star ing up and reducing ofrisk in R&D to creating of the human immune system, ultimately Engineering Manager – Consumer greater efficiencies in how care is delivered. changing the way we approach healthcare and Sweden, Johnson & Johnson optimizing patient outcomes. We are seeing more examples Tiffany Gallagher — Rising Star of how Industry 4.0 is shaping Partner, PwC Transparency the decisions we as leaders are taking when it Technology will continue to comes to investments in technology. move patients to the center and Judy Sewards — Rising Star improve the connectivity and en- VP, Head of Clinical Trial Denise Chambley, Pharm.D. — gagement across the healthcare ecosystem. Experience, Pfizer Rising Star Transparency is the foundation of VP, North America Medical Ponda Motsepe-Ditshego, M.D. trust. Our customers, and impor- Solutions, PHS Health Solutions — Rising Star tantly our colleagues who are driving future One of the trends I see is per- Executive Medical Director, innovation, expect open, accountable, and fecting the right balance between technology Amgen Canada purpose-driven actions and communications. and superb live interactions with our patients Novel bioscience technologies so that we don’t lose the human behind a assist researchers to target specific disease Angela Tenuta — Luminary diagnosis. pathways and develop personalized therapies, Executive VP, Intouch Group using machine learning and AI, which allows Regulated transparency and Melissa Falcone — Rising Star for early disease detection and enhance pa- rapid health-tech advancement VP, Patient Services and tient-centricity. will realign healthcare around Reimbursement,Compliments Mallinckrodt the consumer. More specifically: consumer Pharmaceuticals Stephanie Otis — Rising Star health activism — buckle up. I think about how mobile apps Senior Director, Commercial and telemedicine and wearables impact our Operations, Ferring Audrey Wu — Rising Star ability to help patients manage their disease. Pharmaceuticals VP, ThinkGen At the same time this gives us a huge amount Innovation is intensifying in all We must deliver on changing ex-

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] of data that can be collected and analyzed and areas across the healthcare continuum. The pectations in value creation and put into things like AI to help us further ad- future of the industry is being transformed transparency.

PharmaVOICE  May 2019 48

HBA Special Feature

RISING STARS AMANDA BAUMANN MICHELE IRWIN CUNNINGHAM Senior Director R&D Robotics, VP, Commercial Operations, APOORVA AGGARWAL Stryker Strongbridge Biopharma Principal, ZS Associates Leadership Style: Collaborative Leadership Style: Authenticity Collaborative leadership based I’ve always believed that being yourself on authentic relationships is essential to gain and being authentic are important factors KATHRYN BOYD alignment and to ensure various perspectives are to success, as they sit at the intersection of what you are Business Strategy Senior Manager, considered when making decisions that impact the passionate about and what you are good at. Accenture business.

KIMBERLY ANDERS ELIZABETH DAVIES VP, Acute Sales, Cardinal Health Senior Director, Brand Payer TERENTIA BROWNE Marketing, U.S. Pharmaceuticals, Engineering Manager – Consumer GSK Sweden, Johnson & Johnson Leadership Style: Emotional Leadership Style: Purpose- Intelligence CORI MCKEEVER ASHFORD driven Continual focus on self-awareness and self- Executive VP, Healthcare Practice Lead, Being purpose driven means that I can connect regulation has allowed me to build relationships Central Geo, Weber Shandwick with my team and motivate them to find purpose in a highly matrixed organization, make objective Leadership Style: Integrative and fulfillment in their work. Seeing the value you decisions in times of high uncertainty, and help The best ideas can come from junior add to people and the organization is energizing teams adapt quickly to environmental changes. to senior colleagues and across different disciplines. and contagious. I approach my teams with the mindset that we’ll KARI DELAHUNTY accomplish our greatest success when we seamlessly DENISE CHAMBLEY, PHARM.D. Senior VP, Corporate Strategy, partner and collaborate together. VP, North America Medical Syneos Health Solutions, PHS Health Solutions Leadership Style: Collaboration DOMENICA ASKELAND Leadership Style: Positivity and Execution VP, Global HR Operations, Pfizer Inc. Being positive is a choice. I choose I believe there is a true responsibility when Leadership Style: Transparent and it because looking at the world managing teams, directly or indirectly. I strive Empathetic through an optimistic lens enables me to view to create an environment where trust and Transparency is the key to providing my life, work, challenges, and peoplePharmaVOICE in a more open transparency are part of the culture in order that team with the information they need to be effective in their way. This enables people to feel accepted, be everyone can successfully contribute. We all have roles and for me to earn their respect and trust. Empathy themselves, and be inspired to do their best work. something to contribute, and as a leader, it is allows me to understand my team and provides me with of my responsibility to create an environment and flexibility to respond to critical business issues faster. TIFFANY CHEN, PH.D. culture where people feel engaged to be part of a Directory, Discovery, Rubius successful solution. CAROLE AUGUSTINE Therapeutics Senior Director Business Excellence, Leadership Style: Facilitative LILY DOBBERTEEN Digital Medicine, Otsuka America To achieve highest-quality scientific Project Operations Specialist, Pharmaceutical Inc. results, I aim to build a culture AiCure where individuals and teams are empowered Leadership Style: Confidence to make decisions in a fast-paced, collaborative and Humility ELIZABETH BALTHROP environment. These two qualities mean having the humility DVP, Cardiometabolic and Informatics, to seek more knowledge with the confidence to Rapid Diagnostics, Abbott TRACI CLARKE teach it back. VP, Client Services, The Scienomics Group, An Omnicom Company PRIYA EMMANUEL Managing Director, KPMG SARAH BAST Group VP, Media, Publicis Health Leadership Style: Empowering NICOLE CRAWFORD I am the type of leader who empowers my Executive Business Director, Solid team to take action by giving them the Tumor Northeast Region, Novartis MELISSA FALCONE tools and the confidenceCompliments they need to reach new heights. Oncology VP, Patient Services and Leadership Style: Unboss Reimbursement, Mallinckrodt ALEXANDRA BAUER I provide clarity on objectives for my team and Pharmaceuticals Account Director, Calcium USA create space and flexibility for innovation on the Leadership Style: Shared Leadership Style: Emotional how to achieve. My goal is to serve the team by Vision Intelligence removing barriers while ensuring accountability. If you don’t have a vision for what the future

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] Self-awareness enables me to appreciate It is also important that we have some fun along should look like and a vision that is built with all how my words and actions impact others, which fosters the way. the parties involved you’re not going anywhere; positive and productive relationships with my colleagues then once we have that alignment, I believe that and clients. my team is empowered to do what they do best.

49 May 2019  PharmaVOICE

HBA Special Feature

ADRIANA FERNANDEZ STACEY GIBBONS KAYE KITTREDGE Senior IT Director, Manufacturing VP, Meeting Planning - Speaker Project/Program Manager, Ability and Quality, Eli Lilly Bureau Services, Health & Network, an Inovalon company Leadership Style: Action- Wellness Partners Leadership Style: Servant Oriented and Passion Leadership I like to see results and get things done. I think that Most often, I’m in the company of smart, dedicated to be able to lead I need to demonstrate to the ELLIE HE professionals and the best thing I can offer is to people who surround me — direct reports, peers, Director, Head of Biometrics, help align everyone to a common goal and make senior managers — that I am able to translate Imbrium Therapeutics, a room for their contributions. strategies into actions and get results. I also have a subsidiary of Purdue Pharma passion for the people who work with customers Leadership Style: Bringing out JENNIFER KORNGUT and the patients who we serve. the Best in People Account Supervisor, Havas Good leaders are able to create a supportive Health+ JENNIFER FOLEY environment that will bring out the best in people, Leadership Style: Decisiveness Global Head - Business Insights encourage all the members to develop their skills I have confidence in my ability to & Analytics (BIA), Product and creativity, and inspire the teams to work make quick decisions under pressure. Development Clinical Operations, together toward the common goal. Genentech NATALIA KOTCHIE Leadership Style: Real ELENA HERRERO VP, R&D Applied Data Science I recognize that I’m far from perfect, but know Group Art Supervisor Center, IQVIA that I’m doing the best I can on any given day for Evoke Giant Leadership Style: Adaptability my colleagues and the patients we serve. This Leadership Style: In a rapidly evolving environment, allows me to demand the best from others, but the Resourcefulness and Passion being able to respond to change or make changes grace to be realistic and appreciate that when we With so much happening at our workplaces and is key; this requires listening to others and really struggle, we’re learning. in our industry today, having the ability to take on hearing what they are saying. I am constantly change and adapt to what’s happening around learning from my team and colleagues, and in ALLYSON FUNK us with passion while keeping true engagement order to do that I have found openness and Head of U.S. Communications and top of mind is essential to achieving success in our flexibility invaluable. Public Affairs, UCB ever-changing business environment. Leadership Style: Curious and KELLY LENAHAN Assertive KELLY HORNSBY-CLAWSONPharmaVOICEManager, Scientific and Health From approaching challenges with a learner’s Director, Customer Support, Policy Initiatives, ISPOR—The mindset, asking questions, and understanding the Roche Diabetes Care Professional Society for Health objective, my style is to lead with curiosity. When Leadershipof Style: Relator Economics and Outcomes it comes to action, I am assertive; being a leader I am driven to help people link Research often takes courage and the willingness to make together ideas and resources, solve problems, and Leadership Style: Perseverance decisions. Sometimes we try and fail, but there is simplify complex situations. No matter what is the set back, I always try to find always learning in those experiences and they help a way to move forward, even in moments of the us to keep moving forward. ANN HOWELL most chaos and despair. It has helped strengthen Senior Director, U.S. Regulatory me and motivate me to do better. TIFFANY GALLAGHER Affairs - GDP, Shionogi Partner, PwC LINDA LOUIE Leadership Style: Humility, Executive Director, Accounting, Diplomacy, Open-Mindedness Amgen You can learn from all those around JANNA HUTZ you if you listen, collaborate, and are willing to Senior Director and Head, Data change. Science & Scientific Infrastructure, Eisai BRIDGET MABEY JULIE GARNER Leadership Style: Associate Creative Director, Ogilvy Head of US Government Affairs, Understanding Health AstraZeneca Pharmaceuticals Constantly striving to better understand and Leadership Style: Empathetic communicate our science and my team’s needs is Nurturing relationships within my highest priority. our teams is key to success. When people feel Compliments appreciated and valued, amazing work will follow. SHANNON GATH DANIELLE KING VP, Head of Technology, AMAG Account Service, Fingerpaint MARY MALLANEY Pharmaceuticals Leadership Style: Pragmatic Associate Director, Liso-Cel /CMC Leadership Style: One of the biggest ways I believe Lead, Celgene Empowerment I can support my team is to be a

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] I’m responsible for coalescing the intelligence sound, logical voice that helps to break through of my team to maximize our collective talents. the often frenzied environment of advertising. Through empowerment and supporting their decisions, we contribute to the organization and play a role in the advancement of the company. PharmaVOICE  May 2019 50

HBA Special Feature

SARAH MOOIWEER KATHLEEN PALLADINO MADHURI SHAH Account Supervisor Director of Pharma Account Brand Lead, Rexulti, Lundbeck TBWA\WorldHealth Management, athenahealth Leadership Style: Results- Leadership Style: Empowering Driven I work to give my teammates the It is critical to drive results for the tools and confidence to make decisions on their business, which in turn enables us to help more own. I think all challenges should lead to learnings CHARMAIN PIOTROWSKY patients. Although I am results-driven, how we get and we should all face them with an open mind Regional Business Director, NYC to the results matters to me as well. and without fear. Novo Nordisk Leadership Style: Authentic THAISA SILVESTRE TRACEY MORRISON and Transparent Director, Sales, Brazil, West Director Human Resources, UCB I believe in fostering honest relationships to build Pharmaceutical Services Leadership Style: Authentic trust within my team, which leads to greater loyalty and Resilient and empowerment. I’m authentic in that I am self-aware of my strengths and opportunities. I am a person of SAILETA PRABHU, PH.D. AMI SIMUNOVICH my word and I lead by example. I am also a resilient Senior Director, Development Chief Regulatory Counsel leader as I seek to provide direction through all Sciences, Genentech BD situations. I use my energy to charge others to be Leadership Style: People- Leadership Style: Authentic great. Focused I lead with humility and as a servant I’m always trying to figure out what’s the next best leader. SHENETRA MOSES thing for my people. It’s the same thing I do for my Plant Manager, Baxter organization. LAUREN STEIN International Director, Clinical Marketing, KARA PRICE, PH.D. Performance Health Director, Pharmaceutical Sciences Operations, Merck PONDA MOTSEPE-DITSHEGO, M.D. AMY SULLIVAN Executive Medical Director, Head of Talent Management, Amgen Canada AMRITA RAHMANIPharmaVOICETakeda Pharmaceuticals Inc. Leadership Style: Respectful, Senior Director, Corporate Leadership Style: Coach and Authentic, and Equality Strategy, Regeneron Connector My late father used to say, “you should be able to Pharmaceuticalsof I have navigated through my own career journey converse with the president of the country and by building up my internal network and external similarly converse with the janitor in your building network as well, and I encourage my team to do and treat them exactly the same.” Mutual respect is IRAMIS RALAT the same. important to me and so is how I make people feel. I Director, OSD Manufacturing also care about mentorship and developing people Operations, Bristol-Myers Squibb STEPHANIE TANCK so they can reach their goals. Leadership Style: Authentic Associate Product Manager, Ortho and Empowering Clinical Diagnostics GRETCHEN MURPHY I do step back and accept I don’t have all the Leadership Style: Connector Associate Director, R&D answers. When strategies are not delivering, it’s Being able to see hidden Communications, Public Affairs, time to change to win the game and for that you connections between people and across processes, Alkermes need to empower your team. enables me to connect others to drive synergies and expand value for the organization. It’s also fun JUDY SEWARDS to boot. STEPHANIE OTIS VP, Head of Clinical Trial Senior Director, Commercial Experience, Pfizer ERIKA TORO Operations, Ferring Leadership Style: Customer- Senior Director, Project and Pharmaceuticals Obsessed Program Management, Magellan Leadership Style: Resilient Patients are the reason why we all get up in the Rx Management With the fast pace of change, being resilient morning and do the work we do. Creating a is critically important.Compliments At work and at home, I culture and mindset where customer needs are our look at challenges as opportunities and adapt north star, inspiration, and barometer for decision- MARY TZORTZIS to situations where it is necessary to be agile making, each and every day, not only is good Canada Country Head, Clinical and open to change. Remaining aware, flexible, business but feels good. Study Unit North America, Sanofi and compassionate allows me to understand R&D, Sanofi U.S. the obstacles, quickly adjust to changing RACHEL SEXTON

(c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected] circumstances, and assess ways I can improve and Marketing Innovation & Strategy develop from each experience. Director, Health, RB

51 May 2019  PharmaVOICE

HBA Special Feature

KATHLEEN VEIT KATRINA WEIGOLD MICHELE WYLIE VP, Global Investigations & VP, Global Partners, Medidata Associate Director - Market Access Compliance Monitoring, Teva Operations, Novo Nordisk Pharmaceuticals Leadership Style: Honest and Integrity It’s often trust that connects people successfully DANIELA VERNILLE JENNY WOODWARD from one significant event in time to another. Director of Logistics Solutions and VP, Group Art Supervisor, TBWA\ Building your reputation based on trust and Compliance, Pfizer WorldHealth nurturing it throughout your career is key. Leadership Style: Servant Leadership Style: Committed Leadership I truly value the input and talents of HEATHER ZIGMUND, PHARM.D. It is never about me. It is always about how to everyone I work with and strive to show them my Senior Director, Head of help people succeed in life, realize their vision and dedication to our collective work. Clinical Services, AstraZeneca fulfill their purpose. It is about helping to execute a Pharmaceuticals vision larger than me that will ultimately affect the AUDREY WU Leadership Style: Connecter lives of many others. VP, ThinkGen The fast pace of scientific and technological Leadership Style: Passionate advances requires leaders who are able to bridge LEANNE WALSTRA My passion for what I do fuels my specialized areas to accelerate holistic innovation Group VP, Client Services, The ability to bring my highest and best within the industry. During the course of my career, Lockwood Group to the table and inspires others to do the same. I’ve been able to successfully find common threads Leadership Style: Problem- across disparate areas to drive delivery amid Solver ambiguity. When problems arise, which they often do, I can see through the clutter, identify a clear path, and lead effectively.

RÓISÍN ARMSTRONG, PH.D. BRENDA COOPERSTONE,M.D. LUMINARIES VP, Soliris Medicine Team Leader, Senior VP, Chief Development Alexion Officer, Rare Diseases, Pfizer KRISTIN AINSWORTH Leadership Style:PharmaVOICE Purpose- VP, Corporate Affairs, PR Advocacy Driven and Communications, Tesaro At Alexion, our purpose is to serve patients living Leadership Style: Situational with rare diseases, and itof drives every conversation, DEEPA DESAI, M.D. Years ago, I began to really meeting, and decision I make with my team. By VP, Quality Assurance, IQVIA understand the people on my teams as individuals, keeping patients at the center of all we do, we are Leadership Style: meeting them where they are, and understanding better able to develop and deliver the medicines Compassionate and Influencer how much direction and support they need. Or they need. I enjoy working with employees to in certain cases, I just need to there to be a good develop the confidence to believe in themselves, listener and that allows them to do their thing DIANA BRAINARD, M.D. take ownership to build their careers, and because they’re very experienced. Each day could Senior VP, HIV and Emerging Viral surmount challenges to achieve desired results. be different. Infections, Gilead Sciences BEATRIZ FARO DIVYA ANNAMRAJU Regional President IDM IM, Pfizer Deputy Director, Strategy, Medical Leadership Qualities: Devices Product Supply, Bayer US ERIN BYRCZEK Authenticity, Integrity, Passion Leadership Style: Inclusive VP, U.S. Brands, Pfizer for Diversity Inclusive leaders foster a Leadership Style: Decisive, The decisions that I make both at a personal and collaborative environment that harnesses the Innovation-Oriented, professional level are driven by these values. I richness of diverse perspectives and approaches Empowering fully understand the value of diversity from a of all its team members toward developing I have a proven track record of motivating personal and business point of view and I am fully innovative solutions. As customer needs and multidisciplinary teams and growing talent to over- committed to developing diverse teams. expectations evolve over time, companies with deliver against commercial and financial goals, inclusive cultures will beCompliments better positioned to while evolving our business model to better serve TARA FITZGERALD distinguish themselves as thought leaders. customer needs. President, Clinical Development Services, Syneos Health JESSIE COLLINS Leadership Style: Persistence Senior VP, General Counsel, Because passion never gives up. athenahealth (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]

PharmaVOICE  May 2019 52

HBA Special Feature

BRENDA MCGUIRK FIX VERA IMPER, PH.D. BARBARA MCALEER Senior Marketing Manager, U.S. VP and Head of Business Senior VP Tissue Technology Health and Life Sciences, Microsoft Development, Roche Molecular Operations, Integra LifeSciences Leadership Style: Collaborative Solutions and Communicative Leadership Style: Inclusion I love building teams, working with disparate As a leader, I believe that inclusion drives business stakeholders, launching projects and learning success. By practicing an open door policy, JENNIFER MCGEE which communication style works best. I listen and respecting each individual’s capabilities and VP and Chief Compliance Officer, learn from people with different points of views welcoming diversity of thought, we create a richer, Otsuka America Pharmaceutical and goals. more valuable and inclusive environment. Leadership Style: Team Builder I strive to find opportunities to blend AMY FLOOD ANDREA JOHNSTON people into teams to foster open dialogue and Senior VP, Public Affairs, Gilead President, W2O pure, W2O Group share wins and successes among the team. Sciences Leadership Style: Decisive As a leader, it is often important to SHERI MORIN make decisions efficiently and with Chief Purpose Officer/General clarity. Data-driven, thoughtful decisions made with Manager, Roche CHELSEA GLINSKI speed and transparency are essential in a business Leadership Style: Catalyst Executive Director Reimbursement that moves as fast as marketing communications in I am intensely curious to co-create Strategy, Astellas Pharma US the digital world. the future, while empowering colleagues to reach new levels they may not have thought possible. JACKIE KENT Senior VP, Product, Medidata STEPHANIE NILSEN, PH.D. KRISTEN HEGE, M.D. Senior Director, Operations, Corporate VP, Translational Thermo Fisher Scientific Development, Hematology/ Oncology, Celgene CANDICE LENKOWSKY Head, U.S. Immunoscience Sales, KEIRA O’BRIEN DENISE HENRY Bristol-Myers Squibb VP, Chief Operations Officer, Associate Partner, Director of Leadership Style:PharmaVOICE People-First Government Markets, Magellan Strategic Services & HealthWork, People drive a team’s culture, and Rx Management CDM New York culture will trump strategyof every time. DEBBIE LEONETTI DANIELLE OTTE KATHI HENSON Senior VP, Global Service and VP, Business Development, President, Patient Services, Repair and Sales Operations, Doximity Eversana Integra LifeSciences Leadership Style: Collaborative and Committed It takes a team to deliver extraordinary results and CATHARINA (CANDY) LURKEN CATHERINE OWEN to support the entire organization’s success. Principal, Deloitte Consulting President, Janssen Immunology, Leadership Style: Global Johnson & Johnson CRISTIN HUBBARD Collaborator Leadership Style: Authentic Lifecycle Leader, Hemlibra, Roche Knowing who to connect with and People need to believe in your heart, Leadership Style: Transparency energize across our member firms is important for before they follow your head. and Authenticity creating an impact for our clients. I’m a really big believer that we are LIZ PAULSON all smart adults, we all have integrity, and we all ABIGAIL MALLON Strategic Account Executive want to do the right thing. By equipping people Chief Compliance Officer and LexisNexis Risk Solutions with information upon which they can make good Senior VP, Innovation, VMS Leadership Qualities: decisions, they can best serve patients. When BioMarketing Collaboration, Passion, Focus people walk away from a conversation with me or a meeting with me,Compliments my hope is that they walk away KATHLEEN PEARSON knowing exactly who I am and what I think and SUSANNE MARTZ, M.D. Senior Director – Oncology Market what they’re going to get in the future. Senior VP Global Head Quality, Research/NPP, Eli Lilly GSK Vaccines, GlaxoSmithKline (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]

53 May 2019  PharmaVOICE

HBA Special Feature

JANE PETRINO CHRISTY SIEGEL, PHARM.D. JANANI SWAMY Managing Director, RxMosaic, Head of Immunology, Head of Operational Excellence, Marina Maher Communications Inflammatory Diseases Engineering, Learning & and Transplant, Novartis Development, Sanofi Industrial Pharmaceuticals Affairs, Sanofi U.S.

LEANN PEZDIRTZ CATHY SKALA Head, Field Based Medicine, VP, Business Transformation Office, ANGELA TENUTA Boehringer Ingelheim Baxter International Executive VP, Intouch Group Leadership Style: Leadership Style: Believer Leadership Style: Empowering Facilitative I am a believer in people, their and Courageous The talent, passion, and productivity lie within the potential, and their ability to change, challenge, and team; my goal as a leader is to facilitate harnessing deliver outstanding accomplishments. it to achieve our objectives. TINA VENTURA MEENA SUBRAMANYAM, PH.D. Senior VP, Investor Relations, ANNLEA RUMFOLA VP and Global Program Leader, Horizon Pharma Senior VP, Medical Segment IT, Takeda Pharmaceuticals Cardinal Health Leadership Style: Inspirational I am inquisitive by nature and always ask open-ended questions to encourage critical ELIZABETH WOODY scientific thinking and challenge preconceived VP, Public Affairs, BD KATHY SCHAEFER notions. I empower my team to set a bold vision Leadership Style: A Dealer in Senior VP Finance, Corporate and motivate them to take calculated risks Hope Controller, Mallinckrodt grounded in experiential knowledge as well as The way I try to lead the team and Pharmaceuticals evolving scientific and technical advancements. the way I am inspired is by people. People want to Leadership Style: Adaptable be part of something bigger than themselves and All of my direct reports don’t need the same type want to contribute to something that’s positive. of leadership. Some need more, some need less. As a leader, you have to get to know your people and then understand what their needs are. PharmaVOICE of

Compliments (c) PharmaLinx LLC. Rights do not include promotional use. For distribution or printing rights, contact [email protected]